DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd grew its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 25.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 158,993 shares of the company’s stock after purchasing an additional 32,245 shares during the quarter. Mediolanum International Funds Ltd’s holdings in DocuSign were worth $14,544,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Swedbank AB increased its position in DocuSign by 33.1% during the fourth quarter. Swedbank AB now owns 165,170 shares of the company’s stock worth $14,855,000 after buying an additional 41,039 shares during the period. Stonegate Investment Group LLC acquired a new position in shares of DocuSign in the 4th quarter valued at $216,000. KBC Group NV increased its holdings in shares of DocuSign by 32.7% in the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after acquiring an additional 378,233 shares during the period. Union Bancaire Privee UBP SA acquired a new stake in DocuSign during the 4th quarter worth $96,000. Finally, Blue Trust Inc. grew its position in DocuSign by 52.9% during the 4th quarter. Blue Trust Inc. now owns 2,271 shares of the company’s stock worth $204,000 after purchasing an additional 786 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on DOCU. Piper Sandler upped their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, December 6th. JPMorgan Chase & Co. lifted their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Robert W. Baird upped their price target on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, HSBC reiterated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $92.45.

Insider Transactions at DocuSign

In other news, Director Daniel D. Springer sold 581,588 shares of DocuSign stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the completion of the transaction, the director now owns 906,430 shares of the company’s stock, valued at $87,959,967.20. The trade was a 39.08 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 685,773 shares of company stock valued at $66,032,726 in the last quarter. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Trading Up 0.9 %

Shares of DOCU opened at $96.73 on Friday. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The firm has a market capitalization of $19.54 billion, a P/E ratio of 19.94, a PEG ratio of 8.63 and a beta of 0.88. The firm’s 50-day moving average is $91.05 and its two-hundred day moving average is $72.58.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.